Login  /  Register  | 3 premium articles left before you must register.

New London's LifePharms receives nearly $300,000 to fight fungi

Published May 19. 2012 4:00PM   Updated May 19. 2012 11:20PM

LifePharms, a New London-based biotech company, has secured a $299,998 Small Business Innovation Research grant from the U.S. Department of Health and Human Services.

The Shaw Street drug-discovery company will use the money to research and develop compounds to fight drug-resistant fungi.

“We are looking forward to using these monies to develop several compounds that have shown high potency and activity against drug-resistant strains of fungi,” E. Edward Mena, chief executive officer of LifePharms, said. “Since the population of HIV and immune-compromised patients is growing, the need for novel antifungals, particularly against drug resistant fungi, is urgent.”

U.S. Rep. Joe Courtney, D-2nd District, announced the grant Saturday.

“When I visited LifePharms late last year, I was impressed by their seven-person operation,” Courtney said. “As a strong supporter of SBIR grants, I have no doubt the grant they secured will make a big difference in their ongoing research, and will keep eastern Connecticut on the cutting edge of innovation.”

News by Town

Most Recent Poll
Should the state intervene in the New London school system?
Yes, this should have happened a long time ago.
Yes, I had hoped the city would improve the school system on its own but I now believe state intervention is the only option.
No, local officials should be given more time to turn around the school system.
No, I'm confident the city is already addressing this issue sufficiently.
Number of votes: 1098

No current items found